|
|
| | Atracurium Impurity 26 Besylate Basic information |
| Product Name: | Atracurium Impurity 26 Besylate | | Synonyms: | Atracurium Impurity 26 Besylate;Cisatracurium Besilate Impurity 25;(1R,2S)-1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium Benzenesulfonate;Atracurium Impurity 85;Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2S)-, benzenesulfonate (1:1);Cisatracurium Besilate Impurity 38 | | CAS: | 1075727-02-4 | | MF: | C34H45NO9S | | MW: | 643.79 | | EINECS: | | | Product Categories: | | | Mol File: | 1075727-02-4.mol |  |
| | Atracurium Impurity 26 Besylate Chemical Properties |
| solubility | soluble in Chloroform, Dichloromethane, Methanol | | form | Solid | | color | Off-white |
| | Atracurium Impurity 26 Besylate Usage And Synthesis |
| Uses | (1R,2S)-1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium Benzenesulfonate is an intermediate in the synthesis of (R)-trans-Atracurium Besylate (A794495). (R)-trans-Atracurium Besylate has neuromuscular blocking effects and does not produce cardiovascular effects or increase plasma histamine concentrations. |
| | Atracurium Impurity 26 Besylate Preparation Products And Raw materials |
|